Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
44.00
0.00 (0.00%)
At close: Feb 12, 2026
Market Cap807.64M -6.4%
Revenue (ttm)373.90M +11.8%
Net Income-2.89M
EPS-0.16
Shares Out18.36M
PE Ration/a
Forward PE50.57
Dividendn/a
Ex-Dividend Daten/a
Volume6,955
Average Volume26,305
Open44.00
Previous Close44.00
Day's Range43.40 - 44.50
52-Week Range26.50 - 50.80
Beta-0.06
RSI52.53
Earnings DateMar 27, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements